Skip to main content
Top
Published in: Lung 5/2016

Open Access 01-10-2016

Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD

Authors: Firdaus A. Mohamed Hoesein, Tim Besselink, Esther Pompe, Erik-Jan Oudijk, Ed A. de Graaf, J. M. Kwakkel-van Erp, Pim A. de Jong, Bart Luijk

Published in: Lung | Issue 5/2016

Login to get access

Abstract

Introduction

Pulmonary hypertension (PH) in COPD is associated with a higher mortality and an increased risk on exacerbations compared to COPD patients without PH. The aim was to evaluate the diagnostic value of pulmonary artery (PA) measurements on chest computed tomography (CT) for PH in end-stage COPD.

Methods

COPD patients evaluated for eligibility for lung transplantation between 2004 and 2015 were retrospectively analyzed. Clinical characteristics, chest CTs, spirometry, and right-sided heart catheterizations (RHC) were studied. Diameters of PA and ascending aorta (A) were measured on CT. Diagnostic properties of different cut-offs of PA diameter and PA:A ratio in diagnosing PH were calculated.

Results

Of 92 included COPD patients, 30 (32.6 %) had PH at RHC (meanPAP > 25 mm Hg). PA:A > 1 had a negative predictive value (NPV) of 77.9 % and a positive predictive value (PPV) of 63.1 % with an odds ratio (OR (CI 95 %)) of 5.60 (2.00–15.63). PA diameter ≥30 mm had a NPV of 78 % and PPV of 64 % with an OR (CI 95 %) of 6.95 (2.51–19.24).

Conclusion

A small PA diameter and PA:A make the presence of PH unlikely but cannot exclude its presence in end-stage COPD. A large PA diameter and PA:A maybe used to detect PH early.
Literature
2.
go back to reference Kiely DG, Elliot CA, Sabroe I, Condliffe R (2013) Pulmonary hypertension: diagnosis and management. BMJ 346:f2028CrossRefPubMed Kiely DG, Elliot CA, Sabroe I, Condliffe R (2013) Pulmonary hypertension: diagnosis and management. BMJ 346:f2028CrossRefPubMed
3.
go back to reference Mandel J, Poch D (2013) In the clinic. Pulmonary hypertension. Ann Intern Med 158(9):ITC5-1–16CrossRef Mandel J, Poch D (2013) In the clinic. Pulmonary hypertension. Ann Intern Med 158(9):ITC5-1–16CrossRef
4.
go back to reference Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32:1371–1385CrossRefPubMed Chaouat A, Naeije R, Weitzenblum E (2008) Pulmonary hypertension in COPD. Eur Respir J 32:1371–1385CrossRefPubMed
5.
go back to reference Wrobel JP, Thompson BR, Williams TJ (2012) Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transpl 31:557–564CrossRef Wrobel JP, Thompson BR, Williams TJ (2012) Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transpl 31:557–564CrossRef
6.
go back to reference Adir Y, Shachner R, Amir O, Humbert M (2012) Severe pulmonary hypertension associated with emphysema: a new phenotype? Chest 142(6):1654–1658CrossRefPubMed Adir Y, Shachner R, Amir O, Humbert M (2012) Severe pulmonary hypertension associated with emphysema: a new phenotype? Chest 142(6):1654–1658CrossRefPubMed
7.
go back to reference Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164CrossRefPubMed Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164CrossRefPubMed
8.
go back to reference Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD (2010) Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med 104(12):1877e82CrossRef Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD (2010) Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med 104(12):1877e82CrossRef
9.
go back to reference Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT, COPDGene Investigators, ECLIPSE Study Investigators (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 367(10):913–921CrossRefPubMedPubMedCentral Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT, COPDGene Investigators, ECLIPSE Study Investigators (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 367(10):913–921CrossRefPubMedPubMedCentral
10.
go back to reference Carrington M, Murphy NF, Strange G, Peacock A, McMurray JJ, Stewart S (2008) Prognostic impact of pulmonary arterial hypertension: a population-based analysis. Int J Cardiol 124:183–187CrossRefPubMed Carrington M, Murphy NF, Strange G, Peacock A, McMurray JJ, Stewart S (2008) Prognostic impact of pulmonary arterial hypertension: a population-based analysis. Int J Cardiol 124:183–187CrossRefPubMed
11.
go back to reference Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD (2014) Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. Respir Med 108(11):1626–1632CrossRefPubMed Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD (2014) Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. Respir Med 108(11):1626–1632CrossRefPubMed
12.
go back to reference Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156–163CrossRefPubMed Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156–163CrossRefPubMed
13.
go back to reference Singh VK, George PM, Gries C (2015) Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transpl 34(3):424–429CrossRef Singh VK, George PM, Gries C (2015) Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transpl 34(3):424–429CrossRef
14.
go back to reference Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ (2012) Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186:790–796CrossRefPubMed Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ (2012) Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186:790–796CrossRefPubMed
15.
go back to reference Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137:376–387CrossRefPubMed Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD (2010) Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 137:376–387CrossRefPubMed
16.
go back to reference Simonneau G, Galiè N, Jansa P, Meyer GM, Al-Hiti H, Kusic-Pajic A, Lemarié JC, Hoeper MM, Rubin LJ (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371:2093–2100CrossRefPubMed Simonneau G, Galiè N, Jansa P, Meyer GM, Al-Hiti H, Kusic-Pajic A, Lemarié JC, Hoeper MM, Rubin LJ (2008) Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 371:2093–2100CrossRefPubMed
17.
go back to reference McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, American College of Cardiology Foundation Task Force on Expert Consensus Documents, American Heart Association, American College of Chest Physicians, American Thoracic Society, Inc, Pulmonary hypertension Association (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol 53(17):1573–1619CrossRefPubMed McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J, American College of Cardiology Foundation Task Force on Expert Consensus Documents, American Heart Association, American College of Chest Physicians, American Thoracic Society, Inc, Pulmonary hypertension Association (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol 53(17):1573–1619CrossRefPubMed
18.
go back to reference Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 67(5):735–740CrossRef Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 67(5):735–740CrossRef
19.
go back to reference Janda S, Shahidi N, Gin K, Swiston J (2011) Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 97:612–622CrossRefPubMed Janda S, Shahidi N, Gin K, Swiston J (2011) Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 97:612–622CrossRefPubMed
20.
go back to reference Shen Y, Wan C, Tian P, Wu Y, Li X, Yang T, An J, Wang T, Chen L, Wen F (2014) CT-based pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Med (Baltimore) 93(27):e256CrossRef Shen Y, Wan C, Tian P, Wu Y, Li X, Yang T, An J, Wang T, Chen L, Wen F (2014) CT-based pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review. Med (Baltimore) 93(27):e256CrossRef
21.
go back to reference Ng CS, Wells AU, Padley SP (1999) A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 14(4):270–278CrossRefPubMed Ng CS, Wells AU, Padley SP (1999) A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 14(4):270–278CrossRefPubMed
22.
go back to reference Alhamad EH, Al-Boukai AA, Al-Kassimi FA, Alfaleh HF, Alshamiri MQ, Alzeer AH, Al-Otair HA, Ibrahim GF, Shaik SA (2011) Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology 260(3):875–883CrossRefPubMed Alhamad EH, Al-Boukai AA, Al-Kassimi FA, Alfaleh HF, Alshamiri MQ, Alzeer AH, Al-Otair HA, Ibrahim GF, Shaik SA (2011) Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of CT findings. Radiology 260(3):875–883CrossRefPubMed
23.
go back to reference Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS (2013) Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography. J Thorac Imaging 28(2):96–103CrossRefPubMed Mahammedi A, Oshmyansky A, Hassoun PM, Thiemann DR, Siegelman SS (2013) Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography. J Thorac Imaging 28(2):96–103CrossRefPubMed
24.
go back to reference Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT (2014) CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 145(4):824–832CrossRefPubMed Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT (2014) CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 145(4):824–832CrossRefPubMed
25.
go back to reference Girard A, Jouneau S, Chabanne C, Khouatra C, Lannes M, Traclet J, Turquier S, Delaval P, Cordier JF, Cottin V (2015) Severe pulmonary hypertension associated with COPD: hemodynamic Improvement with specific therapy. Respiration 90(3):220–228CrossRefPubMed Girard A, Jouneau S, Chabanne C, Khouatra C, Lannes M, Traclet J, Turquier S, Delaval P, Cordier JF, Cottin V (2015) Severe pulmonary hypertension associated with COPD: hemodynamic Improvement with specific therapy. Respiration 90(3):220–228CrossRefPubMed
26.
go back to reference Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R (1995) Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198CrossRefPubMed Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R (1995) Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198CrossRefPubMed
27.
go back to reference Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, Videbaek R, Carlsen J (2012) Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transpl 31(4):373–380CrossRef Andersen KH, Iversen M, Kjaergaard J, Mortensen J, Nielsen-Kudsk JE, Bendstrup E, Videbaek R, Carlsen J (2012) Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transpl 31(4):373–380CrossRef
28.
go back to reference Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW, Medical College of Wisconsin Lung Transplant Group (1998) Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 113(5):1250–1256CrossRefPubMed Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW, Medical College of Wisconsin Lung Transplant Group (1998) Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Chest 113(5):1250–1256CrossRefPubMed
29.
go back to reference Ando K, Kuraishi H, Nagaoka T, Tsutsumi T, Hoshika Y, Kimura T, Ienaga H, Morio Y, Takahashi K (2015) Potential role of CT metrics in chronic obstructive pulmonary disease with pulmonary hypertension. Lung 193(6):911–918CrossRefPubMed Ando K, Kuraishi H, Nagaoka T, Tsutsumi T, Hoshika Y, Kimura T, Ienaga H, Morio Y, Takahashi K (2015) Potential role of CT metrics in chronic obstructive pulmonary disease with pulmonary hypertension. Lung 193(6):911–918CrossRefPubMed
30.
go back to reference Dournes G, Laurent F, Coste F, Dromer C, Blanchard E, Picard F, Baldacci F, Montaudon M, Girodet PO, Marthan R, Berger P (2015) Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. Am J Respir Crit Care Med 191(1):63–70CrossRefPubMed Dournes G, Laurent F, Coste F, Dromer C, Blanchard E, Picard F, Baldacci F, Montaudon M, Girodet PO, Marthan R, Berger P (2015) Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. Am J Respir Crit Care Med 191(1):63–70CrossRefPubMed
31.
go back to reference Adir Y, Ollech JE, Vainshelboim B, Shostak Y, Laor A, Kramer MR (2015) The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema. Lung 193(2):223–229CrossRefPubMed Adir Y, Ollech JE, Vainshelboim B, Shostak Y, Laor A, Kramer MR (2015) The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema. Lung 193(2):223–229CrossRefPubMed
32.
go back to reference Minai OA, Fessler H, Stoller JK, Criner GJ, Scharf SM, Meli Y, Nutter B, DeCamp MM, NETT Research Group (2014) Clinical characteristics and prediction of pulmonary hypertension in severe emphysema. Respir Med 108(3):482–490CrossRefPubMed Minai OA, Fessler H, Stoller JK, Criner GJ, Scharf SM, Meli Y, Nutter B, DeCamp MM, NETT Research Group (2014) Clinical characteristics and prediction of pulmonary hypertension in severe emphysema. Respir Med 108(3):482–490CrossRefPubMed
Metadata
Title
Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD
Authors
Firdaus A. Mohamed Hoesein
Tim Besselink
Esther Pompe
Erik-Jan Oudijk
Ed A. de Graaf
J. M. Kwakkel-van Erp
Pim A. de Jong
Bart Luijk
Publication date
01-10-2016
Publisher
Springer US
Published in
Lung / Issue 5/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9926-8

Other articles of this Issue 5/2016

Lung 5/2016 Go to the issue